Larvol Delta - Early-and-sustained-improvement-in-healthrelated-quality-of-life-with-mezagitamab-in-chronicpersistent-immune-thrombocytopenia-Results-from-a-phase-2-randomized-controlled-study

mezagitamab (TAK-079) - Takeda

https://distribution.us.m-anage.com/from.storage?image=8MXTD3tiPM0pgLGzC3Luey5Rmpw7KiJlKr0ebqJJCsbGpiy5zpn59xhddVLZ6kJv0

Suwei Wang 1; Scarlett Wang 1; Magdi Vanya 1; Parth Patwari 1; David Kuter 2

May 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next